Toggle light / dark theme

But that may change soon enough.

A recent study in Nature Communications finally found a possible death cap mushroom antidote. The researchers report that an FDA-approved compound known as indocyanine green (ICG) can inhibit the mushroom’s deadly toxin.

Scientists have been studying death cap mushrooms since the early 1700s but an antidote has largely eluded them because “we know little about how mushroom toxins kill cells,” Qiaoping Wang, a professor of pharmacology at Sun Yat-Sen University and one of the study’s lead authors, told Insider.

Join top executives in San Francisco on July 11–12, to hear how leaders are integrating and optimizing AI investments for success. Learn More

Generative AI has taken the world by storm. So much so that in the last several months, the technology has twice been a major feature on CBS’s “60 Minutes.” The rise of startling conversant chatbots such as ChatGPT has even prompted warnings of runaway technology from some luminary artificial intelligence (AI) experts. While the current state of generative AI is clearly impressive — perhaps dazzling would be a better adjective — it might be even further advanced than is generally understood.

This week, The New York Times reported that some researchers in the tech industry believe these systems have moved toward something that cannot be explained as a “stochastic parrot” — a system that simply mimics its underlying dataset. Instead, they are seeing “An AI system that is coming up with humanlike answers and ideas that weren’t programmed into it.” This observation comes from Microsoft and is based on responses to their prompts from OpenAI’s ChatGPT.